AbbVie
Trade AbbVie 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About ABBV
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.
ABBV Key Statistics
ABBV News
Cantor Fitzgerald analyst Carter Gould raised the firm’s price target on AbbVie (ABBV) to $245 from $215 and keeps an Overweightrating on the shares. AbbVie ann...
If you are trying to figure out what to do with your AbbVie (ABBV) shares, the most recent development might catch your eye. The company just settled with gener...
Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...
Analyst ratings
61%
of 31 ratingsMore ABBV News
The shares of AbbVie (ABBV) climbed nearly 5% on Thursday morning after the American drugmaker reached a settlement with manufacturers producing “generic” or ch...
Healthcare AbbVie settles with generic drugmakers for key immunology drug Rinvoq Sep. 11, 2025 8:01 AM ET AbbVie Inc. (ABBV) Stock By: Dulan Lokuwithana, SA New...
Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...